Vera Therapeutics, Inc. logo VERA - Vera Therapeutics, Inc.

NEXT EARNINGS: Feb 25, 2026 (today) EPS Est: $-1.34
Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
1
BUY 11
HOLD 2
SELL 0
STRONG
SELL
0
| PRICE TARGET: $77.60 DETAILS
HIGH: $97.00
LOW: $33.00
MEDIAN: $90.00
CONSENSUS: $77.60
UPSIDE: 83.15%
Market Cap: 2.97B
Volume: 712,610
Avg Volume: 1,349,711
52 Week Range: 18.53-56.05
Sector: Healthcare
Industry: Biotechnology
Beta: 1.15
Last Dividend: $N/A
Exchange: NASDAQ
Country: US
Employees: 152
IPO Date: 2021-05-14
EPS (TTM): -2.75
P/E Ratio: -15.38
Revenue (TTM): N/A
Total Assets: 655.68M
Total Debt: 54.64M
Cash & Equiv: 92.65M
Rev Growth (5Y): N/A
EPS Growth (5Y): N/A
FCF Growth (5Y): N/A
ROCE: -22.9%
Debt/Equity: 0.09

Earnings History

Date EPS Actual EPS Est EPS Surprise Rev Actual Rev Est Rev Surprise
2025-11-05 $-1.26 $-1.20 -5.0%
2025-08-05 $-1.20 $-0.82 -46.3%
2025-05-06 $-0.81 $-0.75 -8.0%
2025-02-26 $-0.72 $-0.83 +13.3%
2024-11-07 $-0.85 $-0.69 -23.2%
2024-08-08 $-0.62 $-0.58 -6.9%
2024-05-09 $-0.56 $-0.53 -5.7%
2024-03-20 $-0.58 $-0.53 -9.4%

Track Record

Statements >
Metric 2024 2023 2022 2021 2020 2019
Revenue 0 0 0 0 0 0
Net Income (152.15M) (95.99M) (89.06M) (32.61M) (53.41M) (11.85M)
EPS -2.75 -2.25 -3.35 -2.43 -14.40 -3.46
Total Assets 655.68M 175.55M 131.44M 83.75M 54.55M 5.38M
Total Debt 54.64M 53.71M 31.29M 4.92M 2,000 132,000
Cash & Equivalents 92.65M 45.68M 43.46M 79.67M 53.65M 3.19M
Operating Cash Flow (134.68M) (92.18M) (67.60M) (23.71M) (34.81M) (10.29M)
Free Cash Flow (135.65M) (92.24M) (67.66M) (23.71M) (34.91M) (10.41M)
FCF per Share -2.45 -2.16 -2.55 -1.76 -9.41 -3.04
Book Value 577.15M 101.69M 76.91M 69.59M (89.35M) (36.55M)
Cash & ST Investments 640.85M 160.72M 114.65M 79.67M 53.65M 3.19M
ROC Equity -0.26 -0.94 -1.16 -0.47 N/A N/A